ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Immunogenetic, molecular and clinical determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria (2021)
Gurnari, Carmelo; Pagliuca, Simona; Prata, Pedro Henrique de Lima; Catto, Luiz Fernando Bazzo ; Larcher, Lise; Sebert, Marie; Allain, Vincent; Patel, Bhumika J.; Terkawi, Laila; Santos, André Luiz Pinto ; Inacio, Mariana Carolina Beraldo; Hernandez, Lucie; Dhedin, Nathalie; Caillat-Zucman, Sophie; Clappier, Emmanuelle; Fontbrune, Flore Sicre de; Voso, Maria Teresa; Visconte, Valeria; Socie, Gerard; Calado, Rodrigo Tocantins ; Peffault de Latour, Regis; Soulier, Jean; Maciejewski, Jaroslaw P.
Source: Blood. Conference titles: ASH Annual Meeting Abstracts. Unidade: FMRP
Subjects: ANEMIA, CONTAGEM DE CÉLULAS SANGUÍNEAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GURNARI, Carmelo et al. Immunogenetic, molecular and clinical determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-147556. Acesso em: 23 out. 2025. , 2021
APA
Gurnari, C., Pagliuca, S., Prata, P. H. de L., Catto, L. F. B., Larcher, L., Sebert, M., et al. (2021). Immunogenetic, molecular and clinical determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2021-147556
NLM
Gurnari C, Pagliuca S, Prata PH de L, Catto LFB, Larcher L, Sebert M, Allain V, Patel BJ, Terkawi L, Santos ALP, Inacio MCB, Hernandez L, Dhedin N, Caillat-Zucman S, Clappier E, Fontbrune FS de, Voso MT, Visconte V, Socie G, Calado RT, Peffault de Latour R, Soulier J, Maciejewski JP. Immunogenetic, molecular and clinical determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria [Internet]. Blood. 2021 ; 138 602-602.[citado 2025 out. 23 ] Available from: https://doi.org/10.1182/blood-2021-147556
Vancouver
Gurnari C, Pagliuca S, Prata PH de L, Catto LFB, Larcher L, Sebert M, Allain V, Patel BJ, Terkawi L, Santos ALP, Inacio MCB, Hernandez L, Dhedin N, Caillat-Zucman S, Clappier E, Fontbrune FS de, Voso MT, Visconte V, Socie G, Calado RT, Peffault de Latour R, Soulier J, Maciejewski JP. Immunogenetic, molecular and clinical determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria [Internet]. Blood. 2021 ; 138 602-602.[citado 2025 out. 23 ] Available from: https://doi.org/10.1182/blood-2021-147556
Artigo de periodico
Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412 (2014)
Campos, Paula de Melo; Machado Neto, João Agostinho ; Scopim-Ribeiro, Renata; Visconte, Valeria; Tabarroki, Ali; Duarte, Adriana S. S; Barra, Flávia F. C; Vassalo, José; Rogers, Heesun J; Lorand-Metze, Irene; Tiu, Ramon V; Costa, Fernando F; Saad, Sara T. Olalla; Traina, Fabiola
Source: Leukemia Research. Unidade: FMRP
Subjects: APOPTOSE (EFEITOS DE DROGAS), PROTEÍNAS PROTO-ONCOGÊNICAS, PROTEÍNAS QUINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Paula de Melo et al. Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412. Leukemia Research, v. 38, n. 10, p. 1245-1251, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2014.07.010. Acesso em: 23 out. 2025.
APA
Campos, P. de M., Machado Neto, J. A., Scopim-Ribeiro, R., Visconte, V., Tabarroki, A., Duarte, A. S. S., et al. (2014). Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412. Leukemia Research, 38( 10), 1245-1251. doi:10.1016/j.leukres.2014.07.010
NLM
Campos P de M, Machado Neto JA, Scopim-Ribeiro R, Visconte V, Tabarroki A, Duarte ASS, Barra FFC, Vassalo J, Rogers HJ, Lorand-Metze I, Tiu RV, Costa FF, Saad STO, Traina F. Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412 [Internet]. Leukemia Research. 2014 ; 38( 10): 1245-1251.[citado 2025 out. 23 ] Available from: https://doi.org/10.1016/j.leukres.2014.07.010
Vancouver
Campos P de M, Machado Neto JA, Scopim-Ribeiro R, Visconte V, Tabarroki A, Duarte ASS, Barra FFC, Vassalo J, Rogers HJ, Lorand-Metze I, Tiu RV, Costa FF, Saad STO, Traina F. Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412 [Internet]. Leukemia Research. 2014 ; 38( 10): 1245-1251.[citado 2025 out. 23 ] Available from: https://doi.org/10.1016/j.leukres.2014.07.010
Artigo de periodico-carta/editorial
SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype (2013)
Visconte, Valeria; Tabarroki, Ali; Rogers, Heesun J.; Hasrouni, Edy; Traina, Fabiola; Makishima, Hideki; Hamilton, Betty K.; Liu, Yang; O'Keefe, Christine; Lichtin, Alan; Horwitz, Leonard; Sekeres, Mikkael A.; Hsieh, Fred H.; Tiu, Ramon V.
Source: Haematologica. Unidade: FMRP
Subjects: HEMATOLOGIA, CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VISCONTE, Valeria et al. SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.3324/haematol.2013.090506. Acesso em: 23 out. 2025. , 2013
APA
Visconte, V., Tabarroki, A., Rogers, H. J., Hasrouni, E., Traina, F., Makishima, H., et al. (2013). SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.3324/haematol.2013.090506
NLM
Visconte V, Tabarroki A, Rogers HJ, Hasrouni E, Traina F, Makishima H, Hamilton BK, Liu Y, O'Keefe C, Lichtin A, Horwitz L, Sekeres MA, Hsieh FH, Tiu RV. SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype [Internet]. Haematologica. 2013 ; 98( 9): e105-e107.[citado 2025 out. 23 ] Available from: https://doi.org/10.3324/haematol.2013.090506
Vancouver
Visconte V, Tabarroki A, Rogers HJ, Hasrouni E, Traina F, Makishima H, Hamilton BK, Liu Y, O'Keefe C, Lichtin A, Horwitz L, Sekeres MA, Hsieh FH, Tiu RV. SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype [Internet]. Haematologica. 2013 ; 98( 9): e105-e107.[citado 2025 out. 23 ] Available from: https://doi.org/10.3324/haematol.2013.090506

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em

Non normalized affiliation